+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Adderall"

From
Adderall - API Insight, 2022 - Product Thumbnail Image

Adderall - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Adderall- Drug Insight, 2019 - Product Thumbnail Image

Adderall- Drug Insight, 2019

  • Report
  • January 2019
  • 35 Pages
  • Global
From
Global Adderall Drug Market Report and Forecast 2023-2031 - Product Thumbnail Image

Global Adderall Drug Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
  • 8 Results (Page 1 of 1)
Loading Indicator

Adderall is a psychostimulant medication used to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy. It is a combination of amphetamine and dextroamphetamine, which are central nervous system stimulants. Adderall is one of the most commonly prescribed medications for ADHD, and is also used off-label for other mental disorders such as depression and anxiety. Adderall is available in both immediate-release and extended-release forms, and is typically taken orally. It is available in generic form, as well as under the brand names Adderall XR and Mydayis. Common side effects of Adderall include insomnia, dry mouth, loss of appetite, and weight loss. The Adderall market is a large and growing one, with many companies competing for a share of the market. Some of the major players in the Adderall market include Shire Pharmaceuticals, Teva Pharmaceuticals, Actavis, and Mylan. Other companies such as Impax Laboratories, CorePharma, and Mallinckrodt Pharmaceuticals also produce generic versions of Adderall. Show Less Read more